Advances and Challenges of Stimuli-Responsive Nucleic Acids Delivery System in Gene Therapy
Gene therapy has emerged as a powerful tool to treat various diseases, such as cardiovascular diseases, neurological diseases, ocular diseases and cancer diseases. In 2018, the FDA approved Patisiran (the siRNA therapeutic) for treating amyloidosis. Compared with traditional drugs, gene therapy can...
Saved in:
Main Authors: | Meng Lin (Author), Xianrong Qi (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Research Advances in Nucleic Acid Delivery System for Rheumatoid Arthritis Therapy
by: Xintong Zhang, et al.
Published: (2023) -
The Multifaceted Histidine-Based Carriers for Nucleic Acid Delivery: Advances and Challenges
by: Jiaxi He, et al.
Published: (2020) -
Extracellular Vesicles as Delivery Vehicles for Therapeutic Nucleic Acids in Cancer Gene Therapy: Progress and Challenges
by: Rong Du, et al.
Published: (2022) -
Stimuli-responsive drug delivery systems for head and neck cancer therapy
by: Jingou Liang, et al.
Published: (2021) -
Polymeric nanocarriers as stimuli-responsive systems for targeted tumor (cancer) therapy: Recent advances in drug delivery
by: Mosa Alsehli
Published: (2020)